| QLGN Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the QLGN market cap history going back to 5/26/2020:
Also see: QLGN Shares Outstanding History and QLGN YTD Return |
As of 11/14/2025 Qualigen Therapeutics has a market cap of 14.09 million. Investors often follow the QLGN market cap history to compare the size of the company over time.
This page shows QLGN market capitalization trends over time, with 22 market cap datapoints presented, dating back to 5/26/2020.

| QLGN Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the QLGN market cap history going back to 5/26/2020:
Also see: QLGN Shares Outstanding History and QLGN YTD Return |
| QLGN Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||
QLGN Historical Market Cap: -0.40% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||
| QLGN Stock Price Chart |
| About AIxCrypto Holdings Inc |
| Qualigen Therapeutics, Inc. is a clinical-stage therapeutics company. Co. is focused on developing treatments for adult and pediatric cancers. Co.'s business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program (Pan-RAS). Its lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells (such as pancreatic cancer). We show 22 historical shares outstanding datapoints in our QLGN shares outstanding history coverage, used to compute QLGN market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing QLGN market cap history over the course of time is important for investors interested in comparing QLGN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of QLGN versus a peer is one thing; comparing QLGN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like QLGN can fluctuate over the course of history. With this page we aim to empower investors researching QLGN by allowing them to research the QLGN market cap history. |
| QLGN Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: The Importance of Market Cap | |
|
| QLGN Share Performance |
| Market Cap Peers |
| Qualigen Therapeutics (QLGN) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
QNCX Market Cap History QSI Market Cap History QTRX Market Cap History QTTB Market Cap History RAIN Market Cap History RANI Market Cap History RAPP Market Cap History RAPT Market Cap History RARE Market Cap History RARX Market Cap History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.